CPHI Podcast Series: How to leverage AI for Drug Discovery

Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare. 

Bill Whitford is the Life Science Strategic Solutions Leader for the Arcadis DPS Group Strategic Consulting Team supporting innovative biotherapeutic developments and biomanufacturing processes.

He spent his early career as an R&D team lead for Thermo Fisher Scientific and GE Healthcare developing products for biomedical research and therapeutic applications. Products he had commercialised include hybridoma and perfusion cell culture media, products supporting assisted reproduction, and aqueous lipid dispersions.

Bill now publishes on such topics as new biopharmaceutical technologies, Pharma 4.0, and sustainable biomanufacturing practices. He is an author of dozens of journal articles, book chapters, patents, and papers at international conferences and notably received the 2022 APEX Award for Publication Excellence in the Technical & Technology Writing category for his article AI’s Promise for ATMPs published in Pharmaceutical Engineering®. 

In this episode, Bill gives context to the use of AI in different aspects of medicine and drug discovery, including how it can help revamp drug repurposing strategies and save time when searching for drug targets. We also see the implications the technology could have socially, by helping to eliminate bias in clinical trials, and the prospect of how far AI could go. 

Listen to the episode by clicking the button below!